MedX Health Corp
MDXHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 52.8% | -20.3% | -40.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 27.5% | 19.9% | 42.9% | 38.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | -649.6% | -1,052.8% | -1,081.1% | -175.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$1 |
| Pre-Tax Income | -$1 | -$1 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$2 | -$1 |
| % Margin | -948.9% | -1,486.6% | -1,437.5% | -588.1% |
| EPS | -0.004 | -0.005 | -0.006 | -0.004 |
| % Growth | 4.4% | 23.7% | -43.9% | – |
| EPS Diluted | -0.004 | -0.005 | -0.006 | -0.004 |
| Weighted Avg Shares Out | 302 | 291 | 272 | 267 |
| Weighted Avg Shares Out Dil | 302 | 291 | 272 | 267 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | -640.1% | -1,039.9% | -1,070.8% | -169.3% |